Why the FDA Wants More Control Over Some Lab Tests
The FDA finds that many so-called laboratory-derived tests may actually harm patients.
Archives
Breaking the Mold: New Strategies for Fighting Aflatoxins
Pervasive in the developing world, moldy crops threaten millions with cancer and other illnesses.
New Guidelines Allow Some Patients With Chronic Myeloid Leukemia To Go Off Treatment
Most patients with chronic myeloid leukemia (CML) can live out their normal lives by taking tyrosine kinase inhibitors (TKIs). But mounting evidence also shows that roughly a third of those patients can eventually go off treatment altogether without their disease resurging.
Zika in the United States: How Are We Preparing?
Once considered an inconsequential illness, Zika is now linked with serious health effects including microcephaly and Guillain-Barré syndrome. As the virus makes its way northward, U.S. public health agencies are doing their best to prepare.
